Obstetrics/Gynecology
RSSArticles
-
Contraception: More Effective Than Ever?
A new analysis from the National Survey of Family Growth demonstrates a decrease from 12% in 2002 to 10% in 2006-2010 in the overall rate of failure among women using reversible methods of contraception.
-
Nocturnal Enuresis: Are Your Patients Affected?
Nocturnal enuresis was prevalent in women seen in a urogynecology setting and can be associated with nocturia, overactive bladder symptoms, and stress incontinence.
-
Screening, Anticipatory Guidance Needed to Address Teen Sexual Assault
Teens are more likely to delay medical care and less likely to press charges.
-
Minimally Invasive Uterine Fibroid Treatment Underutilized
Use rates particularly low in small and rural hospitals, according to a recent report.
-
More Research Needed on Benefits, Harms of Screening Pelvic Exams
According to one expert: “At this time, there simply is not enough evidence to determine the benefits and harms of using pelvic exams to screen for conditions other than cervical cancer, chlamydia, and gonorrhea.”
-
Check Birth Control Start After Ulipristal Acetate
Results of recent study lead manufacturer of important drug to update its recommendations.
-
New Estimates Show Drop in Annual HIV Infections
Still, much work remains as agencies push for wider access to key resources.
-
Implement Resources for Immediate Postpartum LARC to Cut Unintended Pregnancy
Many women engage in unprotected sex before six-week postpartum visit.
-
Group Prenatal Care
Group prenatal care is a different model for the delivery of prenatal care that typically consists of groups of eight to 12 women of similar gestational age who have each visit together. This contrasts with the one-on-one patient/provider prenatal care visits that are the traditional model. Women are enrolled in group prenatal care after they have had an individual initial prenatal visit and health risk assessment, and have completed the first trimester.
-
More Confusion Over Whether HRT Prevents Dementia
A 20-year prospective cohort study from Finland did not provide strong evidence that hormone replacement therapy prevents dementia except among women who self-reported long-term use.